ctrl K

Watchlist Price Alert

Inhibrx Biosciences Inc. (INBX)

NASDAQ: INBX · Real-Time Price · USD

10.85

-0.43 (-3.81%)

At close: May 14, 2025, 3:59 PM

10.84

-0.09%

After-hours: May 14, 2025, 04:20 PM EDT

Inhibrx Biosciences Revenue Breakdown

Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2020
License, Non-Affiliate Revenue	200K	1.8M	2.18M	10.81M
License, Non-Affiliate Revenue Growth	-88.89%	-17.36%	-79.85%	n/a

Operating Expense Breakdown

Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017
Selling, General, and Administrative Revenue	16.66M	7.9M	93.37M	9.87M	7.79M	7.89M	7.26M	6.4M	5.32M	5.35M	5.4M	5.05M	3.65M	2.85M	2.85M	3.01M	2.21M	1.62M	1.53M	1.47M	4.43M	1.48M	1.64M	1.47M	1.67M	989K	911K	880K
Selling, General, and Administrative Revenue Growth	+110.79%	-91.53%	+845.96%	+26.77%	-1.31%	+8.62%	+13.54%	+20.18%	-0.45%	-1.02%	+6.95%	+38.57%	+27.98%	-0.18%	-5.18%	+35.85%	+36.56%	+5.87%	+4.43%	-66.91%	+199.39%	-9.47%	+11.52%	-12.21%	+68.96%	+8.56%	+3.52%	n/a
Research and Development Revenue	33.37M	38.89M	67.63M	63.59M	81.84M	38.06M	34.11M	37.39M	30.45M	24.93M	29.91M	24.89M	18.61M	18.48M	17.9M	16.44M	17.67M	19.84M	18.97M	17.02M	12.28M	12.79M	12.17M	10.66M	4.68M	8.49M	10.78M	7.29M
Research and Development Revenue Growth	-14.21%	-42.49%	+6.35%	-22.29%	+115.04%	+11.58%	-8.77%	+22.77%	+22.13%	-16.63%	+20.13%	+33.74%	+0.70%	+3.26%	+8.91%	-6.96%	-10.93%	+4.55%	+11.51%	+38.53%	-3.93%	+5.02%	+14.15%	+127.88%	-44.91%	-21.19%	+47.88%	n/a